Ophthalmology Times Europe October 2024

Patients underwent electropuncture, low-intensity laser stimulation of the ciliary muscle, combined therapy and optical-reflex treatment of accommodation

Moving on from medication “stacks” and the old-school reactive approach

Gene therapy for nAMD represents significant advancements in the treatment of retinal conditions

A retrospective analysis illuminates discrepancies between adult and paediatric cataract procedures around the globe

How robotics and gene therapies are shaping retina research, now and in the days to come

Making the most of AI means letting go of fear, says Editorial Advisory Board member Johan Blanckaert, MD

A different approach better serves patients with diabetic retinopathy

Current and future options for Fuchs endothelial corneal dystrophy

Gene therapy was a major topic at the 2024 EURETINA and Retina Society meetings